Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03607617 · ClinicalTrials.gov registry record
ASCEND: ApproacheS to CHC ImplEmeNtation of SDH Data Collection and Action
A clinical trial, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 31
- Enrollment target
NCT03607617: Completed study, sponsored by Kaiser Permanente.
NCT03607617 is a clinical trial that has completed, run by Kaiser Permanente. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03607617 has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
This work will test a set of strategies for helping community health centers (CHCs) routinely identify and take action on the SDH-related needs of patients with / at risk for DM using a stakeholder-driven process to develop EHR-based SDH data collection / summary tools for CHCs.
Primary Outcome
Average differences are reported comparing the pre-intervention period (6 months or more) to (1) the six-month intervention period and (2) the post-intervention period (6 months or more). Numerator is measured as the number of patients with documented social risk screening results entered at a clinical encounter in the measurement period (excluding those only for COVID-19 testing/vaccination, as many people received these services at the study sites who were not otherwise patients at these clini
Interventions
- OTHER SDH Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-09-03 |
| Est. Completion | 2023-07-31 |
What the finished NCT03607617 record still lists
NCT03607617 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which SDH Tool is the first listed.
NCT03607617 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03607617 about?
NCT03607617 is a clinical study titled "ASCEND: ApproacheS to CHC ImplEmeNtation of SDH Data Collection and Action". This work will test a set of strategies for helping community health centers (CHCs) routinely identify and take action on the SDH-related needs of patients with / at risk for DM using a stakeholder-driven process to develop EHR-based SDH data collection / summary tools for CHCs.
What is the current status of trial NCT03607617?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2018-09-03. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT03607617?
The interventions under investigation include: SDH Tool (OTHER).
Who is sponsoring clinical trial NCT03607617?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI